MedPath

Norditropin

These highlights do not include all the information needed to use Norditropin Cartridges safely and effectively. See full prescribing information for Norditropin Cartridges. Norditropin Cartridges [somatropin (rDNA origin) injection], for subcutaneous useInitial U.S. Approval: 1987

Approved
Approval ID

aa9d3467-a450-4b06-885a-7d834dcbddff

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 2, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

somatropin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6146
Application NumberNDA021148
Product Classification
M
Marketing Category
C73594
G
Generic Name
somatropin
Product Specifications
Route of AdministrationSUBCUTANEOUS
Effective DateAugust 11, 2010
FDA Product Classification

INGREDIENTS (8)

PHENOLInactive
Quantity: 4.5 mg in 1.5 mL
Code: 339NCG44TV
Classification: IACT
POLOXAMER 188Inactive
Quantity: 4.5 mg in 1.5 mL
Code: LQA7B6G8JG
Classification: IACT
HISTIDINEInactive
Quantity: 1 mg in 1.5 mL
Code: 4QD397987E
Classification: IACT
SOMATROPINActive
Quantity: 5 mg in 1.5 mL
Code: NQX9KB6PCL
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
MANNITOLInactive
Quantity: 60 mg in 1.5 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norditropin - FDA Drug Approval Details